Kenneth Jun Tao Li
Geen lopende functies
Profiel
Kenneth Jun Tao Li has been a Director of Wex Pharmaceuticals, Inc. since August 2005.
He is Managing Director of Genome & Associates Ltd.
He received a PhD in biochemistry from McGill University in 1978.
Eerdere bekende functies van Kenneth Jun Tao Li
| Bedrijven | Functie | Einde |
|---|---|---|
WEX Pharmaceuticals, Inc.
 WEX Pharmaceuticals, Inc. Medical DistributorsDistribution Services WEX Pharmaceuticals, Inc. develops, manufactures, and sells pharmaceutical products for pain management. The pain management solutions are provided through its proprietary platform technology based on TTX (Tetrodotoxin). It owns and operates its research, development and manufacturing facilities in China through its subsidiaries. The company was founded on June 3, 1987 and is headquartered in Vancouver, Canada. | Directeur/Bestuurslid | - |
Opleiding van Kenneth Jun Tao Li
| McGill University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
WEX Pharmaceuticals, Inc.
WEX Pharmaceuticals, Inc. Medical DistributorsDistribution Services WEX Pharmaceuticals, Inc. develops, manufactures, and sells pharmaceutical products for pain management. The pain management solutions are provided through its proprietary platform technology based on TTX (Tetrodotoxin). It owns and operates its research, development and manufacturing facilities in China through its subsidiaries. The company was founded on June 3, 1987 and is headquartered in Vancouver, Canada. | Distribution Services |
